- $94.42bn
- $89.91bn
- $1.94bn
U.S. STOCKS ON THE MOVE-Strategy, Ecovyst, Azenta
U.S. STOCKS ON THE MOVE-Azenta, Qiagen NV, Capricor Therapeutics
U.S. STOCKS ON THE MOVE-Jersey Mike's Sub, Moderna, PDD Holding
Barclays raises Moderna PT on 'transformative' melanoma vaccine potential
US stocks weekly: Rate rattle
The Week in Breakingviews: The art of IPO pricing
US stocks weekly: Rate rattle
U.S. STOCKS ON THE MOVE-Moderna, O-I Glass, Aveanna Healthcare
Moderna shares whipsaw for third session on cancer vaccine trial data
Arbutus climbs after unveiling buyback from Moderna settlement proceeds
U.S. RESEARCH ROUNDUP-Health Catalyst, Nektar Therapeutics, TIC Solutions
U.S. STOCKS ON THE MOVE-LSI Industries, SiTime, Andersen Group
U.S. STOCKS ON THE MOVE-Apple, Hims & Hers Health, Sysco
Moderna pulls back after massive gains on cancer vaccine trial results
U.S. STOCKS ON THE MOVE-Nordson, Nebius, Deere
Moderna $30 bln gain implies many cancer successes
U.S. STOCKS ON THE MOVE-Walmart, Atour Lifestyle, Wolfspeed
Moderna, Merck fall on profit taking after massive gains on cancer vaccine trial results
Street View: Brokerages cheer Moderna, Merck melanoma vaccine trial win